The doctor-patient relationship in the generative AI era

Five reasons why the time to act for pharma is now.

Ipsos | Ipsos views | Healthcare | Generative AI Generative AI is revolutionising the medical advice landscape, redefining the doctor-patient dynamic in ways previously unimaginable. This brings both huge opportunities and formidable challenges…

Drawing on new research among healthcare professionals, along with our vast experience in this field, we explore these potential impacts in detail.

We also consider the implications for pharmaceutical companies, providing five key reasons why the time for action is now.

We conclude with an incontestable truth: this is a high-risk, high-reward field and the companies that take the lead stand to reap the most significant benefits.

Download our paper

The author(s)

  • Roberto Cortese, Ipsos
    Roberto Cortese
    Senior Director, Syndicated Healthcare Research

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Webinar

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?